title: Effect of graft steatosis on liver function and organ survival after liver transplantation.
abstract: BACKGROUND
  It was the aim to determine the effect of graft steatosis on intraoperative organ blood flow, postoperative liver function, and organ survival.
  
  
  METHODS
  A total of 225 consecutive liver transplants were reviewed. Liver blood flow, hepatic function (AST, ALT, prothrombin time), and organ survival were determined. Donor liver grafts were categorized into 2 subgroups: mild (<30%) (n = 175) and moderate to severe (>/=30%) (n = 50) macrovesicular steatosis.
  
  
  RESULTS
  Moderate to severe steatosis was associated with significantly increased AST and ALT levels and significantly diminished prothrombin time on the first and second postoperative day. By day 7 differences in liver function were no longer evident. Organ blood flow was not affected by steatosis. After adjustment for potential confounders, organ survival did not depend on the degree of donor steatosis (5-year-survival rates: 68% and 58% with steatosis <30%, or >/= 30%, respectively) (hazard ratio .754, confidence interval .458-1.242, P = .268).
  
  
  CONCLUSIONS
  Steatotic livers can be transplanted safely with good results for long-term organ survival if other contraindications are absent.
authors.affiliation: Department of Surgery, Klinikum Grosshadern, Ludwig-Maximilians University Munich, Marchioninistr. 15, D-81377 Munich, Germany.
authors.forename: Martin K
authors.initials: MK
authors.lastname: Angele
authors.forename: Markus
authors.initials: M
authors.lastname: Rentsch
authors.forename: Wolfgang H
authors.initials: WH
authors.lastname: Hartl
authors.forename: Benedikt
authors.initials: B
authors.lastname: Wittmann
authors.forename: Christian
authors.initials: C
authors.lastname: Graeb
authors.forename: Karl Walter
authors.initials: KW
authors.lastname: Jauch
authors.forename: Florian
authors.initials: F
authors.lastname: Loehe
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D001707:Biopsy, Needle; D016009:Chi-Square Distribution; D005234:Fatty Liver / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007150:Immunohistochemistry; D008102:Liver Circulation / Q000502:physiology*; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000009:adverse effects / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000401:mortality; D011336:Probability; D012189:Retrospective Studies; D018570:Risk Assessment; D018709:Statistics, Nonparametric; D015996:Survival Rate; D014019:Tissue Donors; D014184:Transplantation, Homologous